O	O	0	8	Platelet	Platelet	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	8	9	-	-	O	HYPH	I-protein	1	P	I-protein
O	O	9	19	activating	activate	B-VP	VBG	I-protein	4	NMOD	I-protein
O	O	20	26	factor	factor	B-NP	NN	I-protein	5	SUB	I-protein
O	O	27	37	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	O
O	O	38	51	transcription	transcription	B-NP	NN	O	5	OBJ	O
O	O	52	54	of	of	B-PP	IN	O	6	NMOD	O
O	O	55	58	the	the	B-NP	DT	O	14	NMOD	O
T1	B-Protein	59	66	heparin	heparin	I-NP	NN	B-protein	14	NMOD	B-protein
T1	I-Protein	66	67	-	-	O	HYPH	I-protein	14	P	I-protein
T1	I-Protein	67	74	binding	bind	B-VP	VBG	I-protein	14	NMOD	I-protein
T1	I-Protein	75	84	epidermal	epidermal	B-NP	JJ	I-protein	14	NMOD	I-protein
T1	I-Protein	85	91	growth	growth	I-NP	NN	I-protein	14	NMOD	I-protein
T1	I-Protein	92	98	factor	factor	I-NP	NN	I-protein	18	NMOD	I-protein
T1	I-Protein	98	99	-	-	B-NP	HYPH	O	18	NMOD	O
T1	I-Protein	99	103	like	like	I-NP	JJ	O	18	NMOD	O
T1	I-Protein	104	110	growth	growth	I-NP	NN	O	18	NMOD	O
T1	I-Protein	111	117	factor	factor	I-NP	NN	O	7	PMOD	O
O	O	118	120	in	in	B-PP	IN	O	18	NMOD	O
O	O	121	130	monocytes	monocyte	B-NP	NNS	B-cell_type	19	PMOD	B-cell_type
O	O	130	131	.	.	O	.	O	5	P	O

O	O	132	143	Correlation	Correlation	B-NP	NN	O	0	ROOT	O
O	O	144	148	with	with	B-PP	IN	O	1	NMOD	O
O	O	149	151	an	an	B-NP	DT	O	8	NMOD	O
O	O	152	161	increased	increase	I-NP	VBN	O	8	NMOD	O
T9	B-Entity	162	167	kappa	kappa	I-NP	NN	O	8	NMOD	O
T9	I-Entity	168	169	B	B	I-NP	NN	O	8	NMOD	O
O	O	170	177	binding	binding	I-NP	NN	O	8	NMOD	O
O	O	178	186	activity	activity	I-NP	NN	O	2	PMOD	O
O	O	186	187	.	.	O	.	O	1	P	O

O	O	189	194	Human	Human	B-NP	JJ	B-cell_type	3	NMOD	B-cell_type
O	O	195	205	peripheral	peripheral	I-NP	JJ	I-cell_type	3	NMOD	I-cell_type
O	O	206	211	blood	blood	I-NP	NN	I-cell_type	5	SUB	I-cell_type
O	O	212	221	monocytes	monocyte	I-NP	NNS	I-cell_type	3	NMOD	I-cell_type
O	O	222	231	responded	respond	B-VP	VBD	O	0	ROOT	O
O	O	232	234	to	to	B-PP	TO	O	5	VMOD	O
O	O	235	246	stimulation	stimulation	B-NP	NN	O	6	PMOD	O
O	O	247	249	of	of	B-PP	IN	O	7	NMOD	O
O	O	250	258	platelet	platelet	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	258	259	-	-	O	HYPH	I-protein	12	NMOD	I-protein
O	O	259	269	activating	activate	B-VP	VBG	I-protein	12	NMOD	I-protein
O	O	270	276	factor	factor	B-NP	NN	I-protein	8	PMOD	I-protein
O	O	277	278	(	(	O	(	O	15	DEP	O
O	O	278	281	PAF	PAF	B-NP	NN	B-protein	15	DEP	B-protein
O	O	281	282	)	)	O	)	O	12	NMOD	O
O	O	283	287	with	with	B-PP	IN	O	7	NMOD	O
O	O	288	290	up	up	B-ADVP	RB	O	18	AMOD	O
O	O	290	291	-	-	O	HYPH	O	16	PMOD	O
O	O	291	301	regulation	regulation	B-NP	NN	O	18	OBJ	O
O	O	302	304	of	of	B-PP	IN	O	19	NMOD	O
O	O	305	308	the	the	B-NP	DT	O	22	NMOD	O
O	O	309	319	transcript	transcript	I-NP	NN	O	20	PMOD	O
O	O	320	323	for	for	B-PP	IN	O	22	NMOD	O
T2	B-Protein	324	331	heparin	heparin	B-NP	NN	B-protein	29	NMOD	B-protein
T2	I-Protein	331	332	-	-	O	HYPH	I-protein	24	P	I-protein
T2	I-Protein	332	339	binding	bind	B-VP	VBG	I-protein	29	NMOD	I-protein
T2	I-Protein	340	349	epidermal	epidermal	B-NP	JJ	I-protein	29	NMOD	I-protein
T2	I-Protein	350	356	growth	growth	I-NP	NN	I-protein	29	NMOD	I-protein
T2	I-Protein	357	363	factor	factor	I-NP	NN	I-protein	33	NMOD	I-protein
T2	I-Protein	363	364	-	-	B-NP	HYPH	O	33	NMOD	O
T2	I-Protein	364	368	like	like	I-NP	JJ	O	33	NMOD	O
T2	I-Protein	369	375	growth	growth	I-NP	NN	O	33	NMOD	O
T2	I-Protein	376	382	factor	factor	I-NP	NN	O	42	NMOD	O
O	O	383	384	(	(	O	(	O	38	DEP	O
T3	B-Protein	384	386	HB	HB	B-NP	NN	B-protein	37	NMOD	B-protein
T3	I-Protein	386	387	-	-	B-NP	HYPH	I-protein	37	P	I-protein
T3	I-Protein	387	390	EGF	EGF	I-NP	NN	I-protein	38	DEP	I-protein
O	O	390	391	)	)	O	)	O	33	NMOD	O
O	O	391	392	,	,	O	,	O	42	P	O
O	O	393	394	a	a	B-NP	DT	O	42	NMOD	O
O	O	395	401	potent	potent	I-NP	JJ	O	42	NMOD	O
O	O	402	409	mitogen	mitogen	I-NP	NN	B-protein	23	PMOD	B-protein
O	O	410	413	for	for	B-PP	IN	O	42	NMOD	O
O	O	414	422	vascular	vascular	B-NP	JJ	B-cell_type	47	NMOD	B-cell_type
O	O	423	429	smooth	smooth	I-NP	JJ	I-cell_type	47	NMOD	I-cell_type
O	O	430	436	muscle	muscle	I-NP	NN	I-cell_type	47	NMOD	I-cell_type
O	O	437	442	cells	cell	I-NP	NNS	I-cell_type	43	PMOD	I-cell_type
O	O	442	443	.	.	O	.	O	5	P	O

O	O	444	448	This	This	B-NP	DT	O	2	NMOD	O
O	O	449	457	function	function	I-NP	NN	O	5	SUB	O
O	O	458	460	of	of	B-PP	IN	O	2	NMOD	O
O	O	461	464	PAF	PAF	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	465	468	was	be	B-VP	VBD	O	0	ROOT	O
O	O	469	477	observed	observe	I-VP	VBN	O	5	VC	O
O	O	478	480	at	at	B-PP	IN	O	6	VMOD	O
O	O	481	490	nanomolar	nanomolar	B-NP	JJ	O	9	NMOD	O
O	O	491	505	concentrations	concentration	I-NP	NNS	O	7	PMOD	O
O	O	506	508	of	of	B-PP	IN	O	9	NMOD	O
O	O	509	512	the	the	B-NP	DT	O	12	NMOD	O
O	O	513	519	ligand	ligand	I-NP	NN	O	10	PMOD	O
O	O	519	520	,	,	O	,	O	5	P	O
O	O	521	529	starting	start	B-VP	VBG	O	5	VMOD	O
O	O	530	532	at	at	B-PP	IN	O	14	VMOD	O
O	O	533	535	30	30	B-NP	CD	O	17	NMOD	O
O	O	536	539	min	min	I-NP	NN	O	15	PMOD	O
O	O	540	545	after	after	B-PP	IN	O	17	NMOD	O
O	O	546	557	stimulation	stimulation	B-NP	NN	O	18	PMOD	O
O	O	557	558	.	.	O	.	O	5	P	O

O	O	559	562	The	The	B-NP	DT	O	2	NMOD	O
O	O	563	566	PAF	PAF	I-NP	NN	B-protein	13	SUB	B-protein
O	O	566	567	-	-	O	HYPH	O	2	P	O
O	O	567	574	induced	induce	B-VP	VBN	O	2	NMOD	O
O	O	575	577	up	up	B-ADVP	RB	O	7	NMOD	O
O	O	577	578	-	-	B-NP	HYPH	O	5	AMOD	O
O	O	578	588	regulation	regulation	I-NP	NN	O	4	VMOD	O
O	O	589	591	of	of	B-PP	IN	O	7	NMOD	O
T4	B-Protein	592	594	HB	HB	B-NP	NN	B-RNA	12	NMOD	B-RNA
T4	I-Protein	594	595	-	-	B-NP	HYPH	I-RNA	12	NMOD	I-RNA
T4	I-Protein	595	598	EGF	EGF	I-NP	NN	I-RNA	12	NMOD	I-RNA
O	O	599	603	mRNA	mRNA	I-NP	NN	I-RNA	8	PMOD	I-RNA
O	O	604	607	was	be	B-VP	VBD	O	0	ROOT	O
O	O	608	619	accompanied	accompany	I-VP	VBN	O	13	VC	O
O	O	620	622	by	by	B-PP	IN	O	14	VMOD	O
O	O	623	625	an	an	B-NP	DT	O	17	NMOD	O
O	O	626	634	increase	increase	I-NP	NN	O	15	PMOD	O
O	O	635	637	in	in	B-PP	IN	O	17	NMOD	O
T10	B-Entity	638	643	kappa	kappa	B-NP	NN	O	22	NMOD	O
T10	I-Entity	644	645	B	B	I-NP	NN	O	22	NMOD	O
O	O	646	653	binding	binding	I-NP	NN	O	22	NMOD	O
O	O	654	662	activity	activity	I-NP	NN	O	18	PMOD	O
O	O	662	663	.	.	O	.	O	13	P	O

O	O	664	669	These	These	B-NP	DT	O	2	NMOD	O
O	O	670	679	functions	function	I-NP	NNS	O	5	SUB	O
O	O	680	682	of	of	B-PP	IN	O	2	NMOD	O
O	O	683	686	PAF	PAF	B-NP	NN	B-protein	3	PMOD	B-protein
O	O	687	695	appeared	appear	B-VP	VBD	O	0	ROOT	O
O	O	696	698	to	to	I-VP	TO	O	7	VMOD	O
O	O	699	701	be	be	I-VP	VB	O	5	VMOD	O
O	O	702	710	mediated	mediate	I-VP	VBN	O	7	VC	O
O	O	711	718	through	through	B-PP	IN	O	8	VMOD	O
O	O	719	722	the	the	B-NP	DT	O	14	NMOD	O
O	O	723	727	cell	cell	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	728	735	surface	surface	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	736	739	PAF	PAF	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	740	749	receptors	receptor	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	749	750	,	,	O	,	O	5	P	O
O	O	751	753	as	as	B-SBAR	IN	O	5	VMOD	O
O	O	754	757	two	two	B-NP	CD	O	20	NMOD	O
O	O	758	761	PAF	PAF	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	762	770	receptor	receptor	I-NP	NN	O	20	NMOD	O
O	O	771	782	antagonists	antagonist	I-NP	NNS	O	31	SUB	O
O	O	782	783	,	,	O	,	O	26	P	O
O	O	784	787	WEB	WEB	B-NP	NN	O	26	NMOD	O
O	O	788	792	2086	2086	I-NP	CD	O	22	NMOD	O
O	O	793	796	and	and	I-NP	CC	O	26	NMOD	O
O	O	797	798	L	L	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	798	799	-	-	I-NP	HYPH	I-protein	20	NMOD	I-protein
O	O	799	802	659	659	I-NP	CD	I-protein	26	NMOD	I-protein
O	O	802	803	,	,	I-NP	,	O	26	P	O
O	O	803	806	989	989	I-NP	CD	O	20	NMOD	O
O	O	806	807	,	,	O	,	O	20	P	O
O	O	808	815	blocked	block	B-VP	VBD	O	16	SBAR	O
O	O	816	820	both	both	O	CC	O	46	NMOD	O
O	O	821	824	the	the	B-NP	DT	O	46	NMOD	O
O	O	825	827	up	up	I-NP	RB	O	35	AMOD	O
O	O	827	828	-	-	I-NP	HYPH	O	46	NMOD	O
O	O	828	838	regulation	regulation	B-NP	NN	O	46	NMOD	O
O	O	839	841	of	of	B-PP	IN	O	36	NMOD	O
T5	B-Protein	842	844	HB	HB	B-NP	NN	B-RNA	41	NMOD	B-RNA
T5	I-Protein	844	845	-	-	B-NP	HYPH	I-RNA	41	NMOD	I-RNA
T5	I-Protein	845	848	EGF	EGF	I-NP	NN	I-RNA	41	NMOD	I-RNA
O	O	849	853	mRNA	mRNA	I-NP	NN	I-RNA	37	PMOD	I-RNA
O	O	854	857	and	and	O	CC	O	46	NMOD	O
T11	B-Entity	858	863	kappa	kappa	B-NP	NN	O	46	NMOD	O
T11	I-Entity	864	865	B	B	I-NP	NN	O	46	NMOD	O
O	O	866	873	binding	binding	I-NP	NN	O	46	NMOD	O
O	O	874	882	activity	activity	I-NP	NN	O	31	OBJ	O
O	O	883	890	induced	induce	B-VP	VBN	O	46	NMOD	O
O	O	891	893	by	by	B-PP	IN	O	47	VMOD	O
O	O	894	897	PAF	PAF	B-NP	NN	B-protein	48	PMOD	B-protein
O	O	897	898	.	.	O	.	O	5	P	O

O	O	899	902	The	The	B-NP	DT	O	2	NMOD	O
O	O	903	914	antagonists	antagonist	I-NP	NNS	O	6	SUB	O
O	O	914	915	,	,	O	,	O	2	P	O
O	O	916	923	however	however	B-ADVP	RB	O	6	VMOD	O
O	O	923	924	,	,	O	,	O	6	P	O
O	O	925	928	had	have	B-VP	VBD	O	0	ROOT	O
O	O	929	931	no	no	B-NP	DT	O	8	NMOD	O
O	O	932	938	effect	effect	I-NP	NN	O	6	OBJ	O
O	O	939	941	on	on	B-PP	IN	O	6	VMOD	O
O	O	942	949	phorbol	phorbol	B-NP	NN	O	11	NMOD	O
O	O	950	955	ester	ester	I-NP	NN	O	9	PMOD	O
O	O	955	956	-	-	O	HYPH	O	11	P	O
O	O	956	963	induced	induce	B-VP	VBN	O	11	NMOD	O
O	O	964	966	up	up	B-ADVP	RB	O	16	NMOD	O
O	O	966	967	-	-	B-NP	HYPH	O	14	AMOD	O
O	O	967	977	regulation	regulation	I-NP	NN	O	26	NMOD	O
O	O	978	980	of	of	B-PP	IN	O	16	NMOD	O
T6	B-Protein	981	983	HB	HB	B-NP	NN	B-RNA	21	NMOD	B-RNA
T6	I-Protein	983	984	-	-	B-NP	HYPH	I-RNA	21	NMOD	I-RNA
T6	I-Protein	984	987	EGF	EGF	I-NP	NN	I-RNA	21	NMOD	I-RNA
O	O	988	992	mRNA	mRNA	I-NP	NN	I-RNA	17	PMOD	I-RNA
O	O	993	996	and	and	O	CC	O	26	NMOD	O
T12	B-Entity	997	1002	kappa	kappa	B-NP	NN	O	26	NMOD	O
T12	I-Entity	1003	1004	B	B	I-NP	NN	O	26	NMOD	O
O	O	1005	1012	binding	binding	I-NP	NN	O	26	NMOD	O
O	O	1013	1021	activity	activity	I-NP	NN	O	13	VMOD	O
O	O	1021	1022	.	.	O	.	O	6	P	O

O	O	1023	1035	Pretreatment	Pretreatment	B-NP	NN	O	7	SUB	O
O	O	1036	1038	of	of	B-PP	IN	O	1	NMOD	O
O	O	1039	1048	monocytes	monocyte	B-NP	NNS	B-cell_type	2	PMOD	B-cell_type
O	O	1049	1053	with	with	B-PP	IN	O	1	NMOD	O
O	O	1054	1063	pertussis	pertussis	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1064	1069	toxin	toxin	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	1070	1079	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	1080	1085	these	these	B-NP	DT	O	9	NMOD	O
O	O	1086	1095	functions	function	I-NP	NNS	O	7	OBJ	O
O	O	1096	1098	of	of	B-PP	IN	O	9	NMOD	O
O	O	1099	1102	PAF	PAF	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	1102	1103	,	,	O	,	O	7	P	O
O	O	1104	1111	whereas	whereas	O	IN	O	7	VMOD	O
O	O	1112	1119	cholera	cholera	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	1120	1125	toxin	toxin	I-NP	NN	I-protein	16	SUB	I-protein
O	O	1126	1129	had	have	B-VP	VBD	O	13	SBAR	O
O	O	1130	1132	no	no	B-NP	DT	O	19	NMOD	O
O	O	1133	1143	inhibitory	inhibitory	I-NP	JJ	O	19	NMOD	O
O	O	1144	1150	effect	effect	I-NP	NN	O	16	OBJ	O
O	O	1150	1151	.	.	O	.	O	7	P	O

O	O	1152	1163	Pyrrolidine	Pyrrolidine	B-NP	NN	O	2	NMOD	O
O	O	1164	1179	dithiocarbamate	dithiocarbamate	I-NP	NN	O	5	NMOD	O
O	O	1179	1180	,	,	O	,	O	5	P	O
O	O	1181	1183	an	an	B-NP	DT	O	5	NMOD	O
O	O	1184	1193	inhibitor	inhibitor	I-NP	NN	O	14	SUB	O
O	O	1194	1197	for	for	B-PP	IN	O	5	NMOD	O
T13	B-Entity	1198	1200	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T13	I-Entity	1200	1201	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T13	I-Entity	1201	1206	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T13	I-Entity	1207	1208	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	1209	1219	activation	activation	I-NP	NN	O	6	PMOD	O
O	O	1219	1220	,	,	O	,	O	5	P	O
O	O	1221	1229	markedly	markedly	B-ADVP	RB	O	14	VMOD	O
O	O	1230	1237	reduced	reduce	B-VP	VBD	O	0	ROOT	O
O	O	1238	1241	PAF	PAF	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	1241	1242	-	-	O	HYPH	O	21	P	O
O	O	1242	1252	stimulated	stimulate	B-NP	VBN	O	21	NMOD	O
T14	B-Entity	1253	1258	kappa	kappa	I-NP	NN	O	21	NMOD	O
T14	I-Entity	1259	1260	B	B	I-NP	NN	O	21	NMOD	O
O	O	1261	1268	binding	binding	I-NP	NN	O	21	NMOD	O
O	O	1269	1277	activity	activity	I-NP	NN	O	14	OBJ	O
O	O	1278	1280	as	as	B-CONJP	RB	O	21	NMOD	O
O	O	1281	1285	well	well	I-CONJP	RB	O	22	DEP	O
O	O	1286	1288	as	as	I-CONJP	IN	O	22	DEP	O
O	O	1289	1291	up	up	B-ADVP	RB	O	26	AMOD	O
O	O	1291	1292	-	-	O	HYPH	O	22	PMOD	O
O	O	1292	1302	regulation	regulation	B-NP	NN	O	26	OBJ	O
O	O	1303	1305	of	of	B-PP	IN	O	27	NMOD	O
T7	B-Protein	1306	1308	HB	HB	B-NP	NN	B-RNA	32	NMOD	B-RNA
T7	I-Protein	1308	1309	-	-	B-NP	HYPH	I-RNA	32	NMOD	I-RNA
T7	I-Protein	1309	1312	EGF	EGF	I-NP	NN	I-RNA	32	NMOD	I-RNA
O	O	1313	1317	mRNA	mRNA	I-NP	NN	I-RNA	28	PMOD	I-RNA
O	O	1317	1318	.	.	O	.	O	14	P	O

O	O	1319	1324	These	These	B-NP	DT	O	2	NMOD	O
O	O	1325	1332	results	result	I-NP	NNS	O	3	SUB	O
O	O	1333	1340	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1341	1342	a	a	B-NP	DT	O	6	NMOD	O
O	O	1343	1352	potential	potential	I-NP	JJ	O	6	NMOD	O
O	O	1353	1357	role	role	I-NP	NN	O	3	OBJ	O
O	O	1358	1360	of	of	B-PP	IN	O	6	NMOD	O
O	O	1361	1364	PAF	PAF	B-NP	NN	B-protein	7	PMOD	B-protein
O	O	1365	1367	in	in	B-PP	IN	O	6	NMOD	O
T8	B-Protein	1368	1370	HB	HB	B-NP	NN	B-protein	13	NMOD	B-protein
T8	I-Protein	1370	1371	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T8	I-Protein	1371	1374	EGF	EGF	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	1375	1385	expression	expression	I-NP	NN	O	9	PMOD	O
O	O	1386	1389	and	and	O	CC	O	3	VMOD	O
O	O	1390	1397	provide	provide	B-VP	VBP	O	3	VMOD	O
O	O	1398	1406	evidence	evidence	B-NP	NN	O	15	OBJ	O
O	O	1407	1411	that	that	B-SBAR	IN	O	16	NMOD	O
O	O	1412	1416	this	this	B-NP	DT	O	19	NMOD	O
O	O	1417	1428	stimulation	stimulation	I-NP	NN	O	20	SUB	O
O	O	1429	1432	may	may	B-VP	MD	O	17	SBAR	O
O	O	1433	1438	occur	occur	I-VP	VB	O	20	VC	O
O	O	1439	1446	through	through	B-PP	IN	O	21	VMOD	O
O	O	1447	1456	increased	increase	B-NP	VBN	O	27	NMOD	O
T15	B-Entity	1457	1462	kappa	kappa	I-NP	NN	O	27	NMOD	O
T15	I-Entity	1463	1464	B	B	I-NP	NN	O	27	NMOD	O
O	O	1465	1472	binding	binding	I-NP	NN	O	27	NMOD	O
O	O	1473	1481	activity	activity	I-NP	NN	O	22	PMOD	O
O	O	1481	1482	.	.	O	.	O	3	P	O
